The impacts of probiotics in eradication therapy of Helicobacter pylori

• Published in: Archives of microbiology Vol. 204; no. 12; p. 692
• Main Authors: Bai, Xiaofen, Zhu, Minjie, He, Yajun, Wang, Tengyan, Tian, Da, Shu, Jianchang
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2022; Springer Nature B.V
• Subjects: Anti-Bacterial Agents - adverse effects; Antibiotic resistance; Antibiotics; Apoptosis; Archives & records; Autophagy; Biochemistry; Biomedical and Life Sciences; Biotechnology; Cell Biology; Clinical trials; Dietary supplements; Digestive system diseases; Disease; Drug resistance; Dysbacteriosis; Ecology; Eradication; Gastric cancer; Gastritis; Gastroenterology; Gastrointestinal Microbiome; Gene expression; Health hazards; Helicobacter Infections - drug therapy; Helicobacter pylori; Hospitals; Humans; Infections; Life Sciences; Microbial Ecology; Microbiology; Mini Review; Pathogenesis; Peptic ulcers; Probiotics; Probiotics - therapeutic use; Proteins; Side effects; Therapy; Ulcers; Virulence; Eradication therapy; Helicobacter pylori; Probiotics

Helicobacter pylori ( H. pylori ) is a well-known pathogen that infects approximately half of the world’s population. It is a pathogenic agent with potential health hazards related to diverse diseases, especially digestive diseases, such as chronic gastritis, peptic ulcer, and gastric carcinoma. In...